Vernal Biosciences Revenue

Biotechnology Research • Colchester, Vermont, United States • 21-50 Employees

Vernal Biosciences revenue & valuation

Annual revenue	$3,500,000
Revenue per employee	$160,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,200,000
Total funding	$20,000,000

Key Contacts at Vernal Biosciences

Christian Cobaugh

Chief Scientific Officer And Founder

James Clements

Director, Manufacturing Science And Technology

Ryan Nadeau

Associate Director Of Accounting

Company overview

Headquarters	261 Mountain View Drive, Burlington , VT 05446, US
Phone number	+18024401869
Website	vernal.bio
NAICS	541714
Keywords	Cgmp, Infectious Disease, Cell And Gene Therapy, Gene Editing, Ind-Enabling, RUO, Mrna Vaccines, Mrna Therapeutics, Custom Mrna, Discovery/Research, Lnp-Mrna, Phase I Clinical Trial, Phase Ii Clinical Trial, Phase Iii Clinical Trial, Cgmp Mrna Manufacturing, Mrna Cdmo, Mrna Design, Mrna Manufacturing
Founded	2021
Employees	21-50
Socials

Vernal Biosciences Email Formats

Vernal Biosciences uses 2 email formats. The most common is {last name}{last name} (e.g., doedoe@vernal.bio), used 57.1% of the time.

Format	Example	Percentage
{last name}{last name}	doedoe@vernal.bio	57.1%
{last name}{first initial}	doej@vernal.bio	42.9%

About Vernal Biosciences

Vernal Biosciences is a leading provider of high-purity, scalable mRNA manufacturing solutions, enabling researchers and biotech companies to accelerate the development of innovative therapeutics. With deep expertise in mRNA synthesis, LNP formulation, and analytical services, we empower drug discovery and development from early research through clinical trials. Our commitment to quality, flexibility, and scientific partnership ensures that every mRNA project benefits from optimized sequences, robust formulations, and seamless scalability. At Vernal, we are driving the future of medicine—delivering the tools and technologies needed to transform mRNA into life-changing therapies. #mRNA #Biotech #DrugDevelopment #mRNAManufacturing #InnovationForHealth

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Senior

Vice President

Employees by Department

Vernal Biosciences has 11 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Vernal Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-27	4	$20,000,000

Funding Insights

$20,000,000

Total funding amount

$20,000,000

Most recent funding amount

Number of funding rounds

Vernal Biosciences Tech Stack

Discover the technologies and tools that power Vernal Biosciences's digital infrastructure, from frameworks to analytics platforms.

WP Rocket

Caching

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Blocksy

WordPress themes

Cloudflare Rocket Loader

Performance

jQuery

JavaScript libraries

HubSpot Analytics

Analytics

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Gutenberg

Editors

Google Analytics

Analytics

Frequently asked questions

Vernal Biosciences is located in Colchester, Vermont, US.

You can reach Vernal Biosciences at +18024401869.

Vernal Biosciences generates an estimated annual revenue of $3,500,000. This revenue figure reflects the company's market position and business performance in its industry.

Vernal Biosciences has an estimated valuation of $11,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Vernal Biosciences was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Vernal Biosciences has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Vernal Biosciences has raised a total of $20,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.